Focus Stocks
Trading Teva
Published on Wednesday, 18 August 2010 06:40 Written by Danny Miller
New York, August 18th (TradersHuddle.com) - Shares of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) closed the trading session at $50.58 near its 50 day moving average currently set at $51.98. Teva's price action is below this important level, which makes the stock difficult to buy, as there will certainly be resistance as it approaches its 50 day.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $46.99 and calculated resistance at $50.78. These levels will be closely watched by traders, as they provide great insight into the latest price dynamics defined by Teva shares.
Traders should evaluate their trade if they want to establish a position on Teva given the resistance expected as the stock approaches the 50 day moving average. A trade might materialize as the stock manages to break this important level, as it could be used as support going forward, however until the break materializes buying the stock is nothing different than flipping a coin. Other levels that traders will be evaluating are the ones defined by the peak and troughs algorithm that provides great price level reference points.
Related Articles
- Neutral Short Term Pattern on Teva
- ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO
- Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012
- Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference
- Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
- Teva Announces Management Succession
- Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
- Teva Lower With High Volume
- Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
- Teva Announces $3 billion Share Repurchase Program
Related Partner Headlines
- UPDATE: Morgan Stanley Downgrades Teva Pharmaceuticals to Equal-Weight - Benzinga
- Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight - Benzinga
- Teva Gets Upgrade on Revenue Growth - TheStreet.com
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) - TheStreet.com
- Teva Taps Bristol-Myers' Levin as Next CEO - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner - TheStreet.com
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Publicis Groupe: 2011 Annual Results -
VIDEO from Siemens and Synaptic Digital: US Transportation Secretary LaHood to Visit Siemens Light Rail Manufacturing Plant in Sacramento -
Comstock Mining Announces Pricing of Public Offering of Common Stock -
Boeing 787 Dreamliner Debuts in Bangkok for Dream Tour -
SYNC Accelerates into 2013 as Standard Equipment on New Ford Fusion and Flex -
Bacteria Detection Time Cut From Days to Minutes -
Pantone Announces Fashion Color Report Fall 2012 -
Analog Devices’ Webcast Addresses How To Select The Right Differential ADC Driver For Your Design: Part Two










